Active Ingredient: Albendazole Hydatid disease: Treatment of cystic hydatid disease of the liver, lung, and peritoneum caused by the larval form of the dog tapeworm, Echinococcus granulosus.
Neurocysticercosis: Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium.
Use: Off-Label
Microsporidiosis in HIV-infected patients (adolescents and adults)Level of Evidence [G]
Albendazole has activity against Ascaris lumbricoides (roundworm); Ancylostoma caninum; Ancylostoma duodenale and Necator americanus (hookworms); Cutaneous larva migrans; Enterobius vermicularis (pinworm); Giardia duodenalis (giardiasis); Gnathostoma spinigerum; Gongylonema sp; Mansonella perstans (filariasis); Oesophagostomum bifurcum; Opisthorchis sinensis (liver fluke); Trichinella spiralis (Trichinellosis); visceral larva migrans (toxocariasis); liver fluke Clonorchis sinensis; Giardia lamblia; Cysticercus cellulosae; Echinococcus multilocularis
Microsporidiosis (not limited to HIV-infected patients): Disseminated microsporidiosis (E. hellem, E. cuniculi, E. intestinalis, Pleistophora sp, Trachipleistophora sp, Brachiola vesicularum); Intestinal microsporidiosis (Encephalitozoon intestinalis); Ocular microsporidiosis (E. hellem, E. cuniculi, Vittaforma corneae)